SCREENING FOR ADVANCED FIBROSIS AMONG ALASKA NATIVE PEOPLES WITH METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE

被引：0
|
作者：
Johnston, Janet [1 ]
Barbour, Youssef [1 ]
Townshend-Bulson, Lisa [2 ]
Desai, Kena [1 ]
Homan, Chriss [1 ]
Rhodes, Wileina [1 ]
McMahon, Brian [3 ]
机构：
[1] Alaska Nat Tribal Hlth Consortiu, Anchorage, AK USA
[2] Alaska Nat Tribal Consortium, Anchorage, AK USA
[3] Alaska Native Med Ctr, Anchorage, AK USA
来源：
HEPATOLOGY | 2024年 / 80卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
748
引用
收藏
页码：S558 / S559
页数：2
相关论文
共 50 条
  • [21] The Impact of Japanese Dietary Patterns on Metabolic Dysfunction-Associated Steatotic Liver Disease and Liver Fibrosis
    Sasada, Takafumi
    Iino, Chikara
    Sato, Satoshi
    Tateda, Tetsuyuki
    Igarashi, Go
    Yoshida, Kenta
    Sawada, Kaori
    Mikami, Tatsuya
    Nakaji, Shigeyuki
    Sakuraba, Hirotake
    Fukuda, Shinsaku
    NUTRIENTS, 2024, 16 (17)
  • [22] Cardiometabolic phenotype linked to fibrosis and mortality in metabolic dysfunction-associated steatotic liver disease
    Dong, Rui
    Tian, Ting
    Luo, Zhenghan
    Chang, Dongchun
    Xue, Hong
    Qu, Sen
    Wang, Jia
    Shen, Chao
    Zhang, Ru
    Wang, Jie
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2025, 35 (03)
  • [23] Cardiovascular Risk Reduction in Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis
    Bernhard, Johannes
    Galli, Lukas
    Speidl, Walter S.
    Krychtiuk, Konstantin A.
    CURRENT CARDIOLOGY REPORTS, 2025, 27 (01)
  • [24] Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis: The Patient and Physician Perspective
    Eskridge, Wayne
    Cryer, Donna R.
    Schattenberg, Joern M.
    Gastaldelli, Amalia
    Malhi, Harmeet
    Allen, Alina M.
    Noureddin, Mazen
    Sanyal, Arun J.
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (19)
  • [25] Psychosocial risks in metabolic dysfunction-associated steatotic liver disease
    Astrom, Hanne
    Takami Lageborn, Christine
    Hagstrom, Hannes
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2025, 19 (03) : 273 - 290
  • [26] Effect of Pemafibrate on the Lipid Profile, Liver Function, and Liver Fibrosis Among Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease
    Hassan, Mona
    Al-Obaidi, Hasan
    Karrick, Megan
    Merza, Nooraldin
    Nawras, Yusuf
    Saab, Omar
    Al-Obaidi, Ahmed Dheyaa
    Merza, Fatima
    Hashim, Hashim Talib
    Al Zubaidi, Khalid
    Al-Sabbagh, Daniah
    Matbachi, Rand
    Noori, Zainab
    Amatul-Raheem, Hajra
    Mansur, Sarmad
    Al Najafi, Omer
    Algodi, Marwah
    Al Hamdany, Tamarah
    Kobeissy, Abdallah
    GASTROENTEROLOGY RESEARCH, 2024, 17 (04) : 159 - 174
  • [27] Role of Glucocorticoids in Metabolic Dysfunction-Associated Steatotic Liver Disease
    Polyzos, Stergios A.
    Targher, Giovanni
    CURRENT OBESITY REPORTS, 2024, 13 (02) : 242 - 255
  • [28] Update in lean metabolic dysfunction-associated steatotic liver disease
    Sato-Espinoza, Karina
    Chotiprasidhi, Perapa
    Huaman, Mariella R.
    Diaz-Ferrer, Javier
    WORLD JOURNAL OF HEPATOLOGY, 2024, 16 (03) : 452 - 464
  • [29] Mechanobiology in Metabolic Dysfunction-Associated Steatotic Liver Disease and Obesity
    Rudolph, Emily L.
    Chin, LiKang
    CURRENT ISSUES IN MOLECULAR BIOLOGY, 2024, 46 (07) : 7134 - 7146
  • [30] Metabolic dysfunction-associated steatotic liver disease: A silent pandemic
    Samanta, Arghya
    Sen Sarma, Moinak
    WORLD JOURNAL OF HEPATOLOGY, 2024, 16 (04)
12345